查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
皮膚病治療市場：按用途、按藥物類別、按地區 - 規模、份額、展望、機會分析，2022-2028 年
市場調查報告書
商品編碼
1213871

皮膚病治療市場：按用途、按藥物類別、按地區 - 規模、份額、展望、機會分析，2022-2028 年

Dermatological Therapeutic Market, By Application, By Drug Class, By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
出版日期: | 出版商: Coherent Market Insights | 英文 164 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

皮膚科是專門研究皮膚的醫學分支。 皮膚病對人們的生活質量有重大影響。 皮膚病藥物用於治療色素沉著增加的皮膚、皮膚表面重修、皮膚緊緻和與年齡相關的皮膚/血管病變。 由於皮膚科治療是非侵入性的，因此與手術相比，它們耗時更少、成本效益更高，而且效果更好。

市場動態

皮膚病負擔加重、老齡人口增多、對安全有效治療藥物的需求增加、公眾意識增強、研發力度加大、新治療藥物頻繁獲批和上市，這些都是預計將推動全球皮膚病治療市場增長的主要因素。

例如，2022 年 7 月，Almirall 宣布發起第七次提案徵集，旨在通過其開放式創新平台 AlmirallShare 建立皮膚病學研究合作。 目的是為臨床前或臨床開發中的資產確定新的合作機會，這可能會導致皮膚病的新療法。

此外，2021 年 2 月，Bristol-Myers Squibb 評估了 doclavacitinib，一種口服選擇性酪氨酸激□ 2 (TYK2) 抑製劑，用於治療中重度斑塊狀銀屑病患者。四個關鍵階段的積極結果已發表3 次試驗。

這項研究的主要特點

  • 本報告對全球皮膚病藥物市場進行了深入分析，提供了以 2021 年為基準年的預測期 (2022-2028) 的市場規模和復合年增長率 (CAGR%)。我在這裡.
  • 它還揭示了不同細分市場的潛在創收機會，並為市場勾勒出一個有吸引力的投資建議矩陣。
  • 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
  • 根據以下參數對全球皮膚病治療市場的主要參與者進行了概況分析，包括公司亮點、產品組合、主要亮點、績效和戰略。
  • 本研究涵蓋的主要公司包括 Leo Pharma、Pfizer Inc.、Novartis AG、Johnson & Johnson、GlaxoSmithKline PLC、Galderma、Amgen Inc.、Almirall, S.A.、XBiotech USA Inc.、AbbVie Inc. 和 Bausch Health公司，等等。
  • 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
  • 本報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以通過用於分析全球皮膚病治療市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

  • 調查目的
  • 先決條件
  • 縮寫說明

第二章市場展望

  • 報告內容
    • 市場定義和範圍
  • 執行摘要
    • 市場概況：按應用分類
    • 市場概況：按藥物類別
    • 市場概況：按地區
  • 連貫機會圖 (COM)

第 3 章市場動態、法規和趨勢分析

  • 市場動態
    • 全世界皮膚病的增加
    • 特定皮膚病藥物出現嚴重副作用
    • 對安全有效的治療藥物的需求不斷增加
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/批准
  • 害蟲分析
  • 對 PORTER 的分析
  • 併購方案

第 4 章全球皮膚病藥物市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • COVID-19 的流行病學
  • 供應方和需求方分析
  • 經濟影響

第 5 章全球皮膚科應用市場，2017-2028

  • 斑禿
  • 皰疹
  • 銀屑病
  • 酒渣鼻
  • 特應性皮炎
  • 尋常痤瘡
  • 白癜風
  • 水腫
  • 其他用途

第 6 章按藥物類別劃分的全球皮膚病藥物市場，2017-2028

  • 抗感染藥
  • 皮質類固醇
  • 鈣調磷酸□抑製劑
  • 維甲酸
  • 其他藥物類別

第 7 章：2017-2028 年按地區分列的全球皮膚病治療市場

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
  • 世界其他地區

第八章競爭格局

  • Leo Pharma
  • Pfizer Inc.
  • Novartis AG
  • Johnson & Johnson
  • GlaxoSmithKline PLC
  • Galderma
  • Amgen Inc.
  • Almirall, S.A.
  • XBiotech USA Inc.
  • AbbVie Inc.
  • Bausch Health Companies Inc.

第 9 章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5490

Dermatology is an area of medicine dealing specifically with the skin. Skin diseases have a serious impact on people's quality of life. Dermatology therapeutics are used to treat increasing cases of pigmented skin, skin resurfacing, skin tightening, and age-related dermal/vascular lesions, among others. Dermatology treatments are non-invasive require less time, cost-effective, and offer better results as compared to surgeries.

Market Dynamics:

Rise in burden of dermatology diseases, growing geriatric population, rise in demand for safe and effective therapeutics, rise in awareness among people, increase in research and development, and frequent approvals and launches of novel therapeutics are major factors expected to drive growth of the global dermatological therapeutic market.

For instance, in July 2022, Almirall announced the launch of its 7th call through AlmirallShare, its open innovation platform, for proposals to establish collaborations in dermatological research. The aim of this is to find new partnership opportunities for assets in preclinical or clinical development stages that can become new treatments for skin diseases.

Moreover, in February 2021, Bristol Myers Squibb announced positive results from two pivotal Phase 3 trials evaluating deucravacitinib, an oral, selective tyrosine kinase 2 (TYK2) inhibitor, for the treatment of patients with moderate to severe plaque psoriasis.

Key features of the study:

  • This report provides in-depth analysis of the global dermatological therapeutic market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global dermatological therapeutic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Leo Pharma, Pfizer Inc., Novartis AG, Johnson & Johnson, GlaxoSmithKline PLC, Galderma, Amgen Inc., Almirall, S.A., XBiotech USA Inc., AbbVie Inc, and Bausch Health Companies Inc., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global dermatological therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dermatological therapeutic market.

Detailed Segmentation:

  • Global Dermatological Therapeutic Market., By Application:
    • Alopecia
    • Herpes
    • Psoriasis
    • Rosacea
    • Atopic Dermatitis
    • Acne Vulgaris
    • Vitiligo
    • Hidradenitis
    • Other Applications
  • Global Dermatological Therapeutic Market, By Drug Class:
    • Anti-infectives
    • Corticosteroids
    • Calcineurin Inhibitors
    • Retinoids
    • Other Drug Classes
  • Global Dermatological Therapeutic Market, By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa
    • South America
  • Company Profiles:
    • Leo Pharma
    • Pfizer Inc.
    • Novartis AG
    • Johnson & Johnson
    • GlaxoSmithKline PLC
    • Galderma, Amgen Inc.
    • Almirall, S.A.
    • XBiotech USA Inc.
    • AbbVie Inc.
    • Bausch Health Companies Inc.

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Application
    • Market Snapshot, By Drug Class
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing burden of dermatology diseases worldwide
    • Serious side effects of certain dermatological drugs
    • Increase in demand for safe and effective therapeutics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Dermatological Therapeutic Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Dermatological Therapeutic Market, By Application, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Alopecia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Herpes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Psoriasis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Rosacea
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Atopic Dermatitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Acne Vulgaris
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Vitiligo
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Hidradenitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Dermatological Therapeutic Market, By Drug Class, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Anti-infectives
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Calcineurin Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Retinoids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Drug Classes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Dermatological Therapeutic Market, By Geography, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

8. Competitive Landscape

  • Leo Pharma
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Galderma
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Almirall, S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • XBiotech USA Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AbbVie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bausch Health Companies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us